Recruiting studies: Relapsed Ewing Sarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Phase 1/Phase 2 · 22 location(s) · Milton S. Hershey Medical Center · NCT06541262 Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcoma
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT07222735 Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
NA · 16 location(s) · Centre Leon Berard · NCT04055220 Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Phase 1/Phase 2 · 12 location(s) · Milton S. Hershey Medical Center · NCT06465199 Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumor
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT02508038 Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
Phase 2 · 1 location(s) · Istituto Ortopedico Rizzoli · NCT04758000 Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Phase 2 · 3 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT01804634 DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma
Phase 1/Phase 2 · 1 location(s) · Montefiore Medical Center · NCT06892678 Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
Phase 1 · 2 location(s) · Children's National Research Institute · NCT07172958 Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Phase 1 · 8 location(s) · Amgen · NCT07297979 Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Phase 1 · 1 location(s) · Case Comprehensive Cancer Center · NCT05210374 Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Phase 1 · 1 location(s) · New York Medical College · NCT04308330 Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Phase 1/Phase 2 · 15 location(s) · Jazz Pharmaceuticals · NCT05734066 Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adol
Phase 1/Phase 2 · 3 location(s) · David S Shulman, MD · NCT06709495 Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/Phase 2 · 1 location(s) · University of Florida · NCT06625190 Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Phase 1 · 4 location(s) · Children's Hospital of Philadelphia · NCT06156410

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.